- Home
- LODE vs STRO Comparison
LODE vs STRO Comparison
Compare LODE & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LODE
- STRO
- Stock Information
- Founded
- LODE 2008
- STRO 2003
- Country
- LODE United States
- STRO United States
- Employees
- LODE N/A
- STRO N/A
- Industry
- LODE Major Chemicals
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LODE Industrials
- STRO Health Care
- Exchange
- LODE Nasdaq
- STRO Nasdaq
- Market Cap
- LODE 53.0M
- STRO 50.0M
- IPO Year
- LODE N/A
- STRO 2018
- Fundamental
- Price
- LODE $2.51
- STRO $0.87
- Analyst Decision
- LODE Buy
- STRO Hold
- Analyst Count
- LODE 1
- STRO 8
- Target Price
- LODE $26.00
- STRO $6.14
- AVG Volume (30 Days)
- LODE 437.8K
- STRO 2.3M
- Earning Date
- LODE 05-08-2025
- STRO 05-08-2025
- Dividend Yield
- LODE N/A
- STRO N/A
- EPS Growth
- LODE N/A
- STRO N/A
- EPS
- LODE N/A
- STRO N/A
- Revenue
- LODE $3,376,027.00
- STRO $62,043,000.00
- Revenue This Year
- LODE $33.58
- STRO N/A
- Revenue Next Year
- LODE N/A
- STRO $1.29
- P/E Ratio
- LODE N/A
- STRO N/A
- Revenue Growth
- LODE 102.20
- STRO N/A
- 52 Week Low
- LODE $1.30
- STRO $0.52
- 52 Week High
- LODE $10.10
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- LODE 56.92
- STRO 48.53
- Support Level
- LODE $2.39
- STRO $0.80
- Resistance Level
- LODE $2.68
- STRO $1.11
- Average True Range (ATR)
- LODE 0.16
- STRO 0.18
- MACD
- LODE 0.06
- STRO 0.02
- Stochastic Oscillator
- LODE 76.06
- STRO 41.53
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.